Trial Profile
A cross-sectional study in South African HIV-infected children who initiated treatment with ritonavir-boosted lopinavir (LPV/r) and efavirenz
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Nov 2016
Price :
$35
*
At a glance
- Drugs Efavirenz (Primary) ; Lopinavir/ritonavir (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms CHANGES Bone Study
- 11 Nov 2016 New trial record
- 23 Oct 2016 Results published in the AIDS.